Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 12;19(1):339.
doi: 10.1186/s13023-024-03299-3.

Prevalence of hearing loss in pseudohypoparathyroidism

Cassandre Djian  1 , Jugurtha Berkenou  2   3 , Anya Rothenbuhler  2   3 , Jérémie Botton  4 , Agnès Linglart  2   3   5 , Jérôme Nevoux  5   6
Affiliations

Prevalence of hearing loss in pseudohypoparathyroidism

Cassandre Djian et al. Orphanet J Rare Dis. .

Abstract

Background: The main clinical features of pseudohypoparathyroidism (PHP)/inactivating parathyroid hormone/parathyroid hormone-related protein signaling disorders (iPPSD), including parathyroid hormone (PTH) resistance, brachydactyly and short stature, develop during middle and late childhood. Very few studies have addressed hearing loss in PHP/iPPSD patients, and these studies have yielded widely divergent conclusions. The aim of our study was to assess hearing and determine the predictive factors of hearing loss in patients with PHP/iPPSD.

Methods: Our retrospective cohort study was conducted between March 2019 and May 2020 in the Otolaryngology Department and the calcium phosphate reference center for rare diseases in Bicêtre Paris-Saclay Hospital, France. We retrospectively collected data from patients with PHP/iPPSDs (age, sex, genetic mutations, height, body mass index (BMI), PTH resistance, presence or absence of ectopic ossifications and brachydactyly). All patients underwent auditory investigations, including tonal and vocal audiometry. The primary outcome was the pure tone average (PTA). The PTA was compared with the norm according to the International Organization for Standardization. Hearing loss was defined as a PTA ≥ 20 db.

Results: The median age of the patients was 15.6 years [9.5, 28.5]. Thirty-six patients were diagnosed with iPPSD2, and eight were diagnosed with iPPSD3. Twenty-six of them (59%) were female. Hearing impairment was confirmed in 17 patients (39%). The mean PTA and the mean SRT of the deaf ears were 40 ± 26 db and 31 ± 14 db. The mean difference in the PTA between the patients and the normal controls was 11.4 db (p = 0.00002). Short stature and the presence of ectopic ossifications were two significant predictive factors of hearing loss (p = 0.009 and p = 0.03, respectively). Sex, BMI, PTH resistance, mutation category and brachydactyly were not associated with an increased risk of hearing loss (p = 0.19, p = 0.41, p = 0.13, p = 0.50, p = 0.19, respectively).

Conclusion: Our study confirmed the frequency of hearing loss in patients with PHP/iPPSD disease (prevalence = 39%). A diagnosis of PHP/iPPSD should trigger auditory investigations and follow-up, especially when short stature and/or ectopic ossifications are present.

PubMed Disclaimer

Conflict of interest statement

No conflicts of interest

Figures

Fig. 1
Fig. 1
Mean hearing thresholds by age and frequency of patients with pseudohypoparathyroidism and standards from the International Organization for Standardisation
See this image and copyright information in PMC

References

    1. Linglart A, Levine MA, Jüppner H, Pseudohypoparathyroidism. Endocrinol Metab Clin North Am. 2018;47(4):865–88. 10.1016/j.ecl.2018.07.011 - DOI - PMC - PubMed
    1. Linglart A. GNAS-related loss of function disorders and the role of imprinting. Horm Res Paediatr. 2013;79:119–29. 10.1159/000348516 - DOI - PubMed
    1. Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. Pseudohypoparathyroidism - epidemiology, mortality and risk of complications. Clin Endocrinol (Oxf). 2016;84(6):904–11. 10.1111/cen.12948 - DOI - PubMed
    1. Thiele S, Mantovani G, Barlier A, Boldrin V, Bordogna P, De Sanctis L, et al. From pseudohypoparathyroidism to inactivating PTH/PTHrP signalling disorder (iPPSD), a novel classification proposed by the EuroPHP network. Eur J Endocrinol déc. 2016;175(6):P1–17. 10.1530/EJE-16-0107 - DOI - PubMed
    1. Curley KL, Kahanda S, Perez KM, Malow BA, Shoemaker AH. Obstructive sleep apnea and otolaryngologic manifestations in children with pseudohypoparathyroidism. Horm Res Paediatr. 2018;89(3):178–83. 10.1159/000486715 - DOI - PMC - PubMed

Substances

LinkOut - more resources